Group 1 - The company approved a share repurchase plan using its own and self-raised funds, with a maximum repurchase price of RMB 18.00 per share and a total repurchase amount between RMB 100 million and RMB 200 million, to be completed within 12 months [1] - The company received a loan commitment letter from China Merchants Bank Yantai Branch, promising a loan of up to RMB 170 million, which cannot exceed 90% of the actual repurchase amount, with a term of no more than 36 months [1] - The total amount of the repurchase, including the loan and self-funds, will not exceed the upper limit of the repurchase amount, and the actual total will be determined at the end of the repurchase period [1] Group 2 - The share repurchase plan is in response to national policies supporting stock buybacks, aimed at improving the efficiency of the company's capital use, and it does not constitute a related party transaction or significantly impact the company's operations and performance [2] - The company will implement the repurchase plan based on market conditions within the specified period and will fulfill its information disclosure obligations according to relevant laws and regulations [2]
烟台东诚药业集团股份有限公司 关于取得金融机构股票回购专项贷款承诺函的公告